One in three women will become pregnant after an MS diagnosis, therefore consideration of the maternal-infant dyad is needed.

April is dedicated to raising awareness of Parkinson’s disease to support individuals suffering from the condition and those ...

Three companies recently announced progression in their clinical research for next-generation Covid-19 vaccines: INOVIO, ...

Oral triptans are considered the industry gold standard acute treatments and there are currently seven approved, all with ...

Breaking Science Session at the 2025 American Academy of Neurology (AAN) meeting, Remegen announced exciting results from a Phase III clinical trial evaluating the efficacy and safety of telitacicept.

At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine prevention.

Worldwide Clinical Trials (Worldwide) has introduced a new AI-driven tool for improving optimisation of studies.

The trial is expected to enrol 48 subjects with amyotrophic lateral sclerosis across North America. Credit: David Herraez Calzada/Shutterstock. Amylyx Pharmaceuticals has dosed the first subject in ...